Cardiogen at J.P. Morgan 2025
- haraldkattnig5
- Jan 9
- 1 min read
Munich, January 13, 2025 - Cardiogen GmbH, a preclinical clinical life science company focusing on cardiovascular regeneration and cellular reprogramming, is attending the annual J.P. Morgan Healthcare Week in San Francisco.
The company is presenting its technology and clinical therapy program for cardiovascular diseases.
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.